This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sweitzer, S. M. Articles by Yost, M. J. Search for Related Content PubMed PubMed Citation Articles by Sweitzer, S. M. Articles by Yost, M. J. Pubmed/NCBI databases Medline Plus Health Information Diabetes Diabetes Complications Injuries Wounds Social Bookmarking                   What's this?

What Is the Future of Diabetic Wound Care?

From the Department of Surgery (Dr Fann, Dr Yost); the Department of Pharmacology, Physiology, and Neuroscience (Dr Sweitzer); the Department of Cell and Developmental Biology and Anatomy (Dr Borg); and the Department of Chemistry and Biochemistry (Dr Baynes), University of South Carolina, School of Medicine, Columbia, South Carolina.

Correspondence to Sarah M. Sweitzer, PhD, Department of Pharmacology, Physiology, and Neuroscience, University of South Carolina, School of Medicine, Columbia, SC 29208 (sweitzer{at}med.sc.edu).

With diabetes affecting 5% to 10% of the US population, development of a more effective treatment for chronic diabetic wounds is imperative. Clinically, the current treatment in topical wound management includes debridement, topical antibiotics, and a state-of-the-art topical dressing. State-of-the-art dressings are a multi-layer system that can include a collagen cellulose substrate, neonatal foreskin fibroblasts, growth factor containing cream, and a silicone sheet covering for moisture control. Wound healing time can be up to 20 weeks. The future of diabetic wound healing lies in the development of more effective artificial "smart" matrix skin substitutes. This review article will highlight the need for novel smart matrix therapies. These smart matrices will release a multitude of growth factors, cytokines, and bioactive peptide fragments in a temporally and spatially specific, event-driven manner. This timed and focal release of cytokines, enzymes, and pharmacological agents should promote optimal tissue regeneration and repair of full-thickness wounds. Development of these kinds of therapies will require multidisciplinary translational research teams. This review article outlines how current advances in proteomics and genomics can be incorporated into a multidisciplinary translational research approach for developing novel smart matrix dressings for ulcer treatment. With the recognition that the research approach will require both time and money, the best treatment approach is the prevention of diabetic ulcers through better foot care, education, and glycemic control.

The Diabetes Educator, Vol. 32, No. 2, 197-210 (2006)
DOI: 10.1177/0145721706286897


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. R. Yager, R. A. Kulina, and L. A. Gilman Wound Fluids: A Window Into the Wound Environment? International Journal of Lower Extremity Wounds, December 1, 2007; 6(4): 262 - 272. [Abstract] [PDF]

				A. D Metcalfe and M. W.J Ferguson Tissue engineering of replacement skin: the crossroads of biomaterials, wound healing, embryonic development, stem cells and regeneration J R Soc Interface, June 22, 2007; 4(14): 413 - 437. [Abstract] [Full Text] [PDF]